Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Moon-McDermott

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Drug Targeting|August 11, 2000
Bioavailability of a small unilamellar low-clearance liposomal amikacin formulation after extravascular administrationR M Fielding, L Moon-McDermott, R O Lewis
Pharmaceutical Research|December 2, 1998
Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome)R M Fielding, R O Lewis, L Moon-McDermott
Nature Biotechnology|August 1, 1996
An enzyme-linked oligonucleotide assayD W Drolet, L Moon-McDermott, T S Romig
The Journal of Antimicrobial Chemotherapy|April 1, 1984
In-vitro activity of aztreonam in combination with four other antibiotics against gram-negative bacilli and Staphylococcus aureusN M Ampel, L Moon-McDermott, M Keating, et al.
Antimicrobial Agents and Chemotherapy|February 27, 1999
Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkeyR M Fielding, L Moon-McDermott, R O Lewis, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1989
Characterization of a novel insertion of the macrolides-lincosamides-streptogramin B resistance transposon Tn554 in methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidisL E Tillotson, W D Jenssen, L Moon-McDermott, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1984
Comparison of tube dilution and microtitre methods for the detection of antibiotic tolerance in strains of Staphylococcus aureusN M Ampel, M H Keating, L Moon-McDermott, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1987
Molecular epidemiology of macrolides-lincosamides-streptogramin B resistance in Staphylococcus aureus and coagulase-negative staphylococciS Thakker-Varia, W D Jenssen, L Moon-McDermott, et al.
Journal of Liposome Research|June 18, 2009
Evaluating the efficacy of amikacin in low-clearance unilamellar liposomes in a s. Aureus local infection modelA E Garrison, R Bendele, S Knauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecanD L Emerson, R Bendele, E Brown, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Drug Targeting|August 11, 2000
Bioavailability of a small unilamellar low-clearance liposomal amikacin formulation after extravascular administrationR M Fielding, L Moon-McDermott, R O Lewis
Pharmaceutical Research|December 2, 1998
Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome)R M Fielding, R O Lewis, L Moon-McDermott
Nature Biotechnology|August 1, 1996
An enzyme-linked oligonucleotide assayD W Drolet, L Moon-McDermott, T S Romig
The Journal of Antimicrobial Chemotherapy|April 1, 1984
In-vitro activity of aztreonam in combination with four other antibiotics against gram-negative bacilli and Staphylococcus aureusN M Ampel, L Moon-McDermott, M Keating, et al.
Antimicrobial Agents and Chemotherapy|February 27, 1999
Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkeyR M Fielding, L Moon-McDermott, R O Lewis, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1989
Characterization of a novel insertion of the macrolides-lincosamides-streptogramin B resistance transposon Tn554 in methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidisL E Tillotson, W D Jenssen, L Moon-McDermott, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1984
Comparison of tube dilution and microtitre methods for the detection of antibiotic tolerance in strains of Staphylococcus aureusN M Ampel, M H Keating, L Moon-McDermott, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1987
Molecular epidemiology of macrolides-lincosamides-streptogramin B resistance in Staphylococcus aureus and coagulase-negative staphylococciS Thakker-Varia, W D Jenssen, L Moon-McDermott, et al.
Journal of Liposome Research|June 18, 2009
Evaluating the efficacy of amikacin in low-clearance unilamellar liposomes in a s. Aureus local infection modelA E Garrison, R Bendele, S Knauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecanD L Emerson, R Bendele, E Brown, et al.
Pageof 2